- Report
- January 2023
- 146 Pages
North America
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- January 2023
- 153 Pages
Europe
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- October 2022
- 209 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- October 2021
- 215 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- September 2022
- 111 Pages
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 136 Pages
Europe
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 120 Pages
North America
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 133 Pages
Africa, Middle East
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 145 Pages
Asia Pacific
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- June 2022
- 150 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- June 2022
- 140 Pages
Australia
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- April 2023
- 120 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- April 2023
- 113 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- April 2023
- 117 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- August 2022
- 120 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- January 2022
- 115 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- November 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- March 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- February 2022
- 149 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more